Generic Version of Parkinson’s Drug Mirapex Clears FDA Hurdle
Glenmark Generics, Inc., USA, has received tentative approval from the U.S. Food and Drug Administration (FDA) to market pramipexole dihydrochloride, a generic drug used to control symptoms of Parkinson’s disease (PD).
